Odyssey Therapeutics insiders buy shares in show of confidence
Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash
Several insiders at Odyssey Therapeutics (NASDAQ:ODTX) have recently purchased shares, a pattern generally read as a positive signal for shareholders. The largest single purchase came below the current market price, and insider buying has outweighed selling over the past year. Insiders hold 2.4% of the company, worth roughly US$22 million.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.